[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 13 of about 13
1. Wu YN, Jin Y, Pu LY: [Clinical observation on treatment of non-gonococcal cervicitis by integrative medicine]. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Apr;25(4):362-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinical observation on treatment of non-gonococcal cervicitis by integrative medicine].
  • OBJECTIVE: To explore the integrative medicinal therapy for non-gonococcal cervicitis (NGC) in order to elevate the therapeutic effect for patients treated in vain after long-term application of antibiotics.
  • CONCLUSIONS: The therapeutic effect of NGC treated by sensitive antibiotics combined with Qingyuan decoction is better than that treated with western medicine only.

  • MedlinePlus Health Information. consumer health - Antibiotics.
  • MedlinePlus Health Information. consumer health - Herbal Medicine.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15892287.001).
  • [ISSN] 1003-5370
  • [Journal-full-title] Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine
  • [ISO-abbreviation] Zhongguo Zhong Xi Yi Jie He Za Zhi
  • [Language] CHI
  • [Publication-type] Clinical Trial; English Abstract; Journal Article; Randomized Controlled Trial
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 0 / Drugs, Chinese Herbal
  •  go-up   go-down


2. Koh YC, Yoo H: Epithelioid haemangioendothelioma of the sphenoid bone. J Clin Neurosci; 2001 May;8 Suppl 1:63-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Angiogram demonstrated marked neoplastic angiogenesis from the middle meningeal artery and other branches of left external carotid artery, for which preoperative embolisation was tried in vain.
  • Because there is no convincing data to advise radiation/chemotherapy, total resection and close follow-up may be reasonable.
  • [MeSH-minor] Adult. Blood Loss, Surgical / prevention & control. Embolization, Therapeutic. Exophthalmos / etiology. Female. Humans. Neovascularization, Pathologic / etiology. Orbital Neoplasms / complications. Orbital Neoplasms / pathology. Orbital Neoplasms / surgery. Pregnancy. Vision Disorders / etiology

  • MedlinePlus Health Information. consumer health - Postpartum Care.
  • MedlinePlus Health Information. consumer health - Tumors and Pregnancy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2001 Harcourt Publishers Ltd.
  • (PMID = 11386829.001).
  • [ISSN] 0967-5868
  • [Journal-full-title] Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
  • [ISO-abbreviation] J Clin Neurosci
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


3. Suzuki T, Uchida H, Watanabe K, Yagi G, Kashima H: A clinical case series of switching from antipsychotic polypharmacy to monotherapy with a second-generation agent on patients with chronic schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar;28(2):361-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Second-generation antipsychotic medications have become popular as a treatment for schizophrenia.
  • Other psychotropic medications were simplified at the same time.
  • The number of antipsychotic medications and total psychotropic medications were significantly reduced from 3.5 to 1.1 and 6.8 to 2.6, respectively.
  • By showing successful cases, the authors suggest a possibility of antipsychotic monotherapy with a second-generation agent even for those patients who had been treated with high-dose antipsychotic polypharmacy in vain.
  • [MeSH-major] Antipsychotic Agents / therapeutic use. Polypharmacy. Schizophrenia / drug therapy
  • [MeSH-minor] Adult. Chlorpromazine / therapeutic use. Dose-Response Relationship, Drug. Drug Therapy, Combination. Female. Humans. Male. Middle Aged. Patient Readmission. Psychiatric Status Rating Scales. Pulse Therapy, Drug. Retrospective Studies. Salvage Therapy / methods

  • Genetic Alliance. consumer health - Schizophrenia.
  • MedlinePlus Health Information. consumer health - Schizophrenia.
  • Hazardous Substances Data Bank. Chlorpromazine .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 14751434.001).
  • [ISSN] 0278-5846
  • [Journal-full-title] Progress in neuro-psychopharmacology & biological psychiatry
  • [ISO-abbreviation] Prog. Neuropsychopharmacol. Biol. Psychiatry
  • [Language] eng
  • [Publication-type] Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antipsychotic Agents; U42B7VYA4P / Chlorpromazine
  •  go-up   go-down


Advertisement
4. Lin H, Huang EY, Chang HY, ChangChien CC: Therapeutic effect of topical applications of trichloroacetic acid for vaginal intraepithelial neoplasia after hysterectomy. Jpn J Clin Oncol; 2005 Nov;35(11):651-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Therapeutic effect of topical applications of trichloroacetic acid for vaginal intraepithelial neoplasia after hysterectomy.
  • OBJECTIVE: We attempted to evaluate the therapeutic effect of trichloroacetic acid (TCA) for vaginal intraepithelial neoplasia (VaIN) after hysterectomy and to identify factors affecting persistence/recurrence.
  • METHODS: Twenty-eight post-hysterectomy patients with various grades of VaIN were enrolled in this study between January 2001 and December 2003.
  • RESULTS: In 20 of 28 patients (71.4%) VaIN went into remission.
  • Treatment success was observed in all 11 patients with VaIN I, whereas only 9 out of 17 patients (53%) with VaIN II/III went into remission (P = 0.009).
  • Severity of VaIN was the only significant independent predictor of persistence/recurrence (odds ratio = 3.5; 95% confidence interval = 1.1, 11.6; P = 0.038).
  • The treatment was well tolerated with no major side effects.
  • CONCLUSIONS: Based on our findings, 50% TCA was a potential agent with minimal side effects for low-grade VaIN.
  • However, as for high-grade lesions, further investigation with different TCA concentration is compelling.
  • [MeSH-major] Carcinoma in Situ / drug therapy. Hysterectomy. Trichloroacetic Acid / therapeutic use. Vaginal Neoplasms / drug therapy
  • [MeSH-minor] Administration, Topical. Adult. Aged. Drug Administration Schedule. Female. Humans. Middle Aged. Neoplasm Recurrence, Local / drug therapy. Postoperative Care

  • MedlinePlus Health Information. consumer health - Hysterectomy.
  • MedlinePlus Health Information. consumer health - Vaginal Cancer.
  • Hazardous Substances Data Bank. TRICHLOROACETIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16275678.001).
  • [ISSN] 0368-2811
  • [Journal-full-title] Japanese journal of clinical oncology
  • [ISO-abbreviation] Jpn. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 5V2JDO056X / Trichloroacetic Acid
  •  go-up   go-down


5. Liou LM, Shih PY: Successful treatment of rubral tremor by high-dose trihexyphenidyl: a case report. Kaohsiung J Med Sci; 2006 Mar;22(3):149-53
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Successful treatment of rubral tremor by high-dose trihexyphenidyl: a case report.
  • Moreover, some rhythmic, coarse, low-frequency (2-3 Hz) oscillation over the right wrist and elbow was noted 1 month later.
  • Rubral tremor is not unusual, and pharmacotherapy is nearly always ineffective in clinical practice.
  • In our patient, we tried valproate, clonazepam, and verapamil one after another, but all in vain.
  • [MeSH-major] Ataxia / drug therapy. Trihexyphenidyl / therapeutic use

  • Genetic Alliance. consumer health - Tremor.
  • Hazardous Substances Data Bank. TRIHEXYPHENIDYL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16602280.001).
  • [ISSN] 1607-551X
  • [Journal-full-title] The Kaohsiung journal of medical sciences
  • [ISO-abbreviation] Kaohsiung J. Med. Sci.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China (Republic : 1949- )
  • [Chemical-registry-number] 6RC5V8B7PO / Trihexyphenidyl
  •  go-up   go-down


6. Li H, Geng L, Guo YL, Guo HY, You K, Qiao J: [Analysis of diagnosis and treatment of vaginal intraepithelial neoplasia and correlation to cervical intraepithelial neoplasia]. Zhonghua Fu Chan Ke Za Zhi; 2009 Mar;44(3):171-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Analysis of diagnosis and treatment of vaginal intraepithelial neoplasia and correlation to cervical intraepithelial neoplasia].
  • OBJECTIVE: To investigate the diagnosis and therapy of vaginal intraepithelial neoplasia (VAIN) and correlation to cervical intraepithelial neoplasia (CIN).
  • METHODS: The clinical and pathological data about age, liquid-based cytology, human papillomavirus (HPV) DNA test, colposcopy, histology types and treatment in 35 patients with VAIN were reviewed to investigate the diagnosis and therapy of VAIN and correlation to CIN.
  • 8% (1/13) of patients were younger than 40 years developed VAINIII, while 18% (4/22) patients were elder than 40 years.
  • VAINII-III accounted for 3/9, 53% (8/15) and 4/6 of CINI, CINII-III and cervical cancer, respectively.
  • There were 97% (33/34) cases with abnormality for liquid-based cytology and 86% (30/35) cases of lesions were located in the upper 1/3 vagina.
  • Among 19 cases received therapy, 14 cases (74%) were treated by surgery, 2 cases (11%) by brachytherapy, 3 cases (16%) used drug on the surface of vagina and the lesions were shown recovery in 9 cases followed up.
  • CONCLUSION: The clinical characteristics of VAIN are similar to CIN and the principles of diagnosis and treatment are also the same as that of CIN.
  • [MeSH-major] Carcinoma in Situ / diagnosis. Carcinoma in Situ / therapy. Uterine Cervical Neoplasms / diagnosis. Uterine Cervical Neoplasms / therapy. Vaginal Neoplasms / diagnosis. Vaginal Neoplasms / therapy
  • [MeSH-minor] Adult. Aged. Antineoplastic Agents / therapeutic use. Cervical Intraepithelial Neoplasia / diagnosis. Cervical Intraepithelial Neoplasia / pathology. Cervical Intraepithelial Neoplasia / therapy. Colposcopy. Cytodiagnosis / methods. Female. Follow-Up Studies. Humans. Hysterectomy. Middle Aged. Neoplasm Staging. Papillomaviridae / isolation & purification. Papillomavirus Infections / complications. Papillomavirus Infections / diagnosis. Retrospective Studies. Treatment Outcome. Young Adult


7. González Sánchez JL, Flores Murrieta G, Chávez Brambila J, Deolarte Manzano JM, Andrade Manzano AF: [Topical 5-fluorouracil for treatment of vaginal intraepithelial neoplasms]. Ginecol Obstet Mex; 2002 May;70:244-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Topical 5-fluorouracil for treatment of vaginal intraepithelial neoplasms].
  • [Transliterated title] 5-fluorouracilo tópico en el tratamiento de la neoplasia intraepitelial vaginal.
  • OBJECTIVE: Our purpose was to determine the effectiveness of 5-fluorouracil (5-FU) in the treatment of vaginal intraepithelial neoplasia (VAIN).
  • MATERIALS AND METHODS: The study was performed in 30 patients with a mean age of 54 years and previous diagnoses from reviewed records and histopathology slides selected from a group of 65 patients with VAIN from 1980 to 1998.
  • Patients received intravaginal treatment with 5-FU, 1.5 g once weekly for 10 weeks and all patients were followed up for at least 2-years.
  • RESULTS: Twenty eight (93%) patients with VAIN had prior or concurrent anogenital squamous neoplasia, including 5 with invasive cervical carcinoma and 23 with cervical intraepithelial neoplasia.
  • In 23 of 30 treated patients (77%), VAIN went into remission after a single treatment; in 3, (10%), it went into remission after two treatment; 3 (10%) had recurrent VAIN 3; and in 1 (3%) it progressed to invasive vaginal cancer.
  • The treatment was well tolerated.
  • CONCLUSIONS: The 5-FU is an option choice for VAIN treatment.
  • Its use should be confined to treating extensive or multifocal high-grade VAIN.
  • [MeSH-major] Antimetabolites, Antineoplastic / therapeutic use. Cervical Intraepithelial Neoplasia / drug therapy. Fluorouracil / therapeutic use. Vaginal Neoplasms / drug therapy
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Middle Aged. Papanicolaou Test. Papilloma / drug therapy. Papilloma / pathology. Uterine Cervical Neoplasms / drug therapy. Uterine Cervical Neoplasms / pathology. Vaginal Smears

  • MedlinePlus Health Information. consumer health - Vaginal Cancer.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12148464.001).
  • [ISSN] 0300-9041
  • [Journal-full-title] Ginecología y obstetricia de México
  • [ISO-abbreviation] Ginecol Obstet Mex
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Mexico
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; U3P01618RT / Fluorouracil
  •  go-up   go-down


8. Hoshimoto S, Morise Z, Takeura C, Ikeda M, Kagawa T, Tanahashi Y, Okabe Y, Mizoguchi Y, Sugioka A: Malignant Triton tumor in the retroperitoneal space associated with neurofibromatosis type 1: a case study. Rare Tumors; 2009;1(2):e27
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant Triton tumor in the retroperitoneal space associated with neurofibromatosis type 1: a case study.
  • We report an extremely rare case of malignant Triton tumor developing in the retroperitoneal space in a patient with neurofibromatosis type 1.
  • A 21-year old man who had been diagnosed with neurofibromatosis type 1 was admitted to our hospital with the chief complaint of a palpable abdominal mass.
  • Abdominal computed tomography revealed a huge heterogeneous tumor measuring approximately 17 cm in diameter occupying the left retroperitoneal space, and numerous metastatic lesions between the left psoas muscle and the left thigh with dissolution of the left hip joint.
  • After the diagnosis of a retroperitoneal malignant neurogenic tumor, resection of the tumor with reconstruction of the abdominal aorta was conducted, followed by postoperative transarterial infusion chemotherapy.
  • The histopathological diagnosis was malignant peripheral nerve sheath tumor with rhabdomyosarcomatous differentiation, namely malignant Triton tumor.
  • Postoperative chemotherapy was in vain and the patient died 14 months after the surgery as a result of lung metastasis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21139906.001).
  • [ISSN] 2036-3613
  • [Journal-full-title] Rare tumors
  • [ISO-abbreviation] Rare Tumors
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  • [Other-IDs] NLM/ PMC2994481
  • [Keywords] NOTNLM ; malignant Triton tumor / malignant peripheral nerve sheath tumor / neurofibromatosis / retroperitoneal tumor.
  •  go-up   go-down


9. Bergh J: Adjuvant chemotherapy for breast cancer--"one fits all"? Breast; 2005 Dec;14(6):564-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adjuvant chemotherapy for breast cancer--"one fits all"?
  • Adjuvant breast cancer therapy and early diagnosis will improve breast cancer outcome.
  • So far, the very important survival gains by adjuvant therapy have been obtained by "one fits all"--like strategies, resulting in therapy in vain for many patients and unnecessary therapy for large cohorts.
  • Present adjuvant strategies have focused on group statistical risk analysis, mainly using tumour stage, histological grade and receptor status.
  • Five retrospective studies have revealed a worse outcome for patients receiving adjuvant chemotherapy without toxicity.
  • In one of these studies the breast cancer survival was improved by 10% for patients who received grade 2/3 neutropenia; this is equivalent to the described survival gains by the addition of anthracyclines and taxanes to cyclophosphamide, methotrexate, 5-fluorouracil (CMF) combinations.
  • Prospectively, this has been explored in the Scandinavian Breast Group (SBG) 9401-, SBG 2000-1- and presently in the SBG 2004-1 studies using tailored chemotherapy dosage strategies, aimed at avoiding under-dosage and diminishing acute side effects.
  • For the future, we need several predictive factors for therapy, allowing better and more tailored therapy selections for individuals at risk.
  • The present explorations of tumour RNA expression profiles are most likely to be useful in identifying therapy-predictive profiles for these individuals.
  • Pharmacokinetic and pharmacodynamic data reveal marked differences in effect and tolerance of used drugs.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Breast Neoplasms / drug therapy
  • [MeSH-minor] Chemotherapy, Adjuvant. Combined Modality Therapy. Europe. Female. Humans. Patient-Centered Care. Randomized Controlled Trials as Topic. Survival Analysis

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16243525.001).
  • [ISSN] 0960-9776
  • [Journal-full-title] Breast (Edinburgh, Scotland)
  • [ISO-abbreviation] Breast
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Scotland
  • [Number-of-references] 46
  •  go-up   go-down


10. Indraccolo U, Del Frate E, Cenci S, Ubertosi M, Donati Sarti R, Donati Sarti C, Baldoni A: [Vaginal intraepithelial neoplasia and human papillomavirus infection: a report of 75 cases]. Minerva Ginecol; 2006 Apr;58(2):101-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Vaginal intraepithelial neoplasia and human papillomavirus infection: a report of 75 cases].
  • [Transliterated title] La neoplasia intraepiteliale vaginale e l'infezione da virus del papilloma umano. Un resoconto di 75 casi.
  • AIM: Vaginal intraepithelial neoplasia (VaIN) is an uncommon and poorly understood disease.
  • Risk factors other than human papillomavirus (HPV) infection could be linked to the onset and evolution of some VaIN.
  • METHODS: In this paper, the results achieved from the analysis of 75 patients with VaIN are reported.
  • From these cases, women with HIV, previous hysterectomy, autoimmune diseases and radio- and chemotherapy have been excluded.
  • They have been examined after a distinction between grade and association with coilocytosis.
  • VaIN preferential localization, mean age of patients and manifestation pattern after vaginal colposcopy have then been examined.
  • RESULTS: Although the population size cannot allow evidences, it seems that VaIN with coilocytosis and VaIN I without coilocytosis have preferential localization in the upper third of the vagina.
  • It does not appear that mean age of patients for each grade of VaIN differs significativly, both associated and not associated with coilocytosis.
  • Finally, after vaginal colposcopy, the pattern of VaIN for each grade is absolutely not typical, and it seems that white thin epithelium or negative Lugol area are usually the manifestation of high grades of VaIN too.
  • CONCLUSIONS: These results, if confirmed, could mean that VaIN due to HPV may have a different natural history relating to the site of localization in the vagina and, moreover, that also VaIN of high grade could appear with an innocent vaginal pattern.
  • [MeSH-major] Carcinoma in Situ / complications. Carcinoma in Situ / pathology. Papillomaviridae. Papillomavirus Infections / complications. Papillomavirus Infections / pathology. Vaginal Neoplasms / complications. Vaginal Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Vaginal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16582866.001).
  • [ISSN] 0026-4784
  • [Journal-full-title] Minerva ginecologica
  • [ISO-abbreviation] Minerva Ginecol
  • [Language] ita
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


11. Sholomskas DE, Syracuse-Siewert G, Rounsaville BJ, Ball SA, Nuro KF, Carroll KM: We don't train in vain: a dissemination trial of three strategies of training clinicians in cognitive-behavioral therapy. J Consult Clin Psychol; 2005 Feb;73(1):106-15
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] We don't train in vain: a dissemination trial of three strategies of training clinicians in cognitive-behavioral therapy.
  • There has been little research on the effectiveness of different training strategies or the impact of exposure to treatment manuals alone on clinicians' ability to effectively implement empirically supported therapies.
  • Seventy-eight community-based clinicians were assigned to 1 of 3 training conditions: review of a cognitive-behavioral therapy (CBT) manual only, review of the manual plus access to a CBT training Web site, or review of the manual plus a didactic seminar followed by supervised casework.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2005 APA.
  • [Cites] JAMA. 1999 Oct 13;282(14):1314-6 [10527162.001]
  • [Cites] JAMA. 1999 Sep 1;282(9):861-6 [10478693.001]
  • [Cites] J Consult Clin Psychol. 1999 Aug;67(4):563-70 [10450627.001]
  • [Cites] Arch Gen Psychiatry. 1999 Jun;56(6):493-502 [10359461.001]
  • [Cites] J Consult Clin Psychol. 1998 Jun;66(3):484-92 [9642886.001]
  • [Cites] J Consult Clin Psychol. 1998 Apr;66(2):290-303 [9583332.001]
  • [Cites] Ann Emerg Med. 1998 Mar;31(3):364-9 [9506495.001]
  • [Cites] J Consult Clin Psychol. 1997 Oct;65(5):821-33 [9337501.001]
  • [Cites] Psychol Bull. 1997 Sep;122(2):170-91 [9283299.001]
  • [Cites] J Gen Intern Med. 1997 May;12(5):274-83 [9159696.001]
  • [Cites] J Consult Clin Psychol. 1995 Feb;63(1):70-8 [7896993.001]
  • [Cites] Arch Gen Psychiatry. 1994 Mar;51(3):177-87 [8122955.001]
  • [Cites] J Consult Clin Psychol. 1993 Aug;61(4):620-30 [8370857.001]
  • [Cites] Compr Psychiatry. 1986 Jul-Aug;27(4):364-71 [3524986.001]
  • [Cites] J Consult Clin Psychol. 1982 Oct;50(5):744-56 [7142549.001]
  • [Cites] Am J Psychiatry. 1982 Nov;139(11):1442-6 [7137394.001]
  • [Cites] Arch Gen Psychiatry. 2004 Mar;61(3):264-72 [14993114.001]
  • [Cites] J Subst Abuse Treat. 2002 Dec;23(4):309-18 [12495792.001]
  • [Cites] Med Educ. 2002 Feb;36(2):125-34 [11869439.001]
  • [Cites] Addiction. 2001 Dec;96(12):1725-42 [11784466.001]
  • [Cites] J Consult Clin Psychol. 2001 Dec;69(6):1007-17 [11777104.001]
  • [Cites] Behav Res Methods Instrum Comput. 2001 May;33(2):277-81 [11447684.001]
  • [Cites] Psychol Addict Behav. 2001 Jun;15(2):83-8 [11419234.001]
  • [Cites] Drug Alcohol Depend. 2000 Jan 1;57(3):225-38 [10661673.001]
  • [Cites] Drug Alcohol Depend. 2000 Feb 1;58(1-2):55-66 [10669055.001]
  • [Cites] Addiction. 2010 Oct;105(10):1799-808 [20840200.001]
  • [Cites] Psychol Bull. 1979 Mar;86(2):420-8 [18839484.001]
  • (PMID = 15709837.001).
  • [ISSN] 0022-006X
  • [Journal-full-title] Journal of consulting and clinical psychology
  • [ISO-abbreviation] J Consult Clin Psychol
  • [Language] ENG
  • [Grant] United States / NIAAA NIH HHS / AA / R44 AA014456-02; United States / NIDA NIH HHS / DA / K05 DA000457-02; United States / NIDA NIH HHS / DA / P50 DA009241-12; United States / NIDA NIH HHS / DA / DA015969-03; United States / NIDA NIH HHS / DA / R37 DA015969-04; United States / NIDA NIH HHS / DA / DA009241-11; United States / NIDA NIH HHS / DA / DA011352-01; United States / NIDA NIH HHS / DA / R44 DA 11352; United States / NIDA NIH HHS / DA / K05 DA000089-21; United States / NIDA NIH HHS / DA / DA000089-22; United States / NIDA NIH HHS / DA / R44 DA011352-03; United States / NIDA NIH HHS / DA / K05-DA00457; United States / NIAAA NIH HHS / AA / AA014456-02; United States / NIDA NIH HHS / DA / DA011352-03; United States / NIDA NIH HHS / DA / K05 DA000457-05; United States / NIDA NIH HHS / DA / DA000089-21; United States / NIDA NIH HHS / DA / P50 DA009241; United States / NIDA NIH HHS / DA / K05 DA000089-22; United States / NIDA NIH HHS / DA / R43 DA011352-01; United States / NIDA NIH HHS / DA / DA000089-20; United States / NIDA NIH HHS / DA / DA009241-12; United States / NIDA NIH HHS / DA / P50 DA009241-10; United States / NIDA NIH HHS / DA / K05 DA000457; United States / NIDA NIH HHS / DA / R01 DA015969; United States / NIDA NIH HHS / DA / R37 DA015969-02; United States / NIDA NIH HHS / DA / DA011352-02; United States / NIDA NIH HHS / DA / DA015969-01; United States / NIDA NIH HHS / DA / K05 DA000457-06; United States / NIDA NIH HHS / DA / P50 DA009241-11; United States / NIDA NIH HHS / DA / R37 DA015969-03; United States / NIDA NIH HHS / DA / DA000457-02; United States / NIDA NIH HHS / DA / DA015969-04; United States / NIDA NIH HHS / DA / K05 DA000457-04; United States / NIDA NIH HHS / DA / K05 DA00089; United States / NIDA NIH HHS / DA / DA015969-02; United States / NIDA NIH HHS / DA / P50 DA09241; United States / NIDA NIH HHS / DA / R01 DA015969-01; United States / NIDA NIH HHS / DA / K05 DA000089; United States / NIDA NIH HHS / DA / DA000457-06; United States / NIDA NIH HHS / DA / DA009241-10; United States / NIDA NIH HHS / DA / DA000457-05; United States / NIDA NIH HHS / DA / DA000457-04; United States / NIDA NIH HHS / DA / K05 DA000089-20; United States / NIDA NIH HHS / DA / R44 DA011352-02; United States / NIDA NIH HHS / DA / DA000457-03; United States / NIDA NIH HHS / DA / K05 DA000457-03; United States / NIDA NIH HHS / DA / R37 DA015969
  • [Publication-type] Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS46425; NLM/ PMC2367057
  •  go-up   go-down


12. Pahuja A, Bashir J, Williamson EM, Barber N: Unresolved priapism secondary to tamsulosin. Int J Impot Res; 2005 May-Jun;17(3):293-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tamsulosin is the most potent adrenergic alpha-1 antagonist used for the treatment of benign prostatic hyperplasia.
  • Initial treatment consisted of aspiration and intracavernosal irrigation of iced saline and vasoconstrictive agent, but in vain.
  • We then performed Winters procedure but that too failed and the priapism persisted.
  • Health-care professionals should inform all patients taking such medications about rare but possible serious adverse effects.
  • [MeSH-minor] Blood Flow Velocity. Humans. Male. Middle Aged. Penis / blood supply. Penis / ultrasonography. Prostatic Hyperplasia / drug therapy

  • Genetic Alliance. consumer health - Priapism.
  • Hazardous Substances Data Bank. Tamsulosin .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15549140.001).
  • [ISSN] 0955-9930
  • [Journal-full-title] International journal of impotence research
  • [ISO-abbreviation] Int. J. Impot. Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Adrenergic alpha-Antagonists; 0 / Sulfonamides; G3P28OML5I / tamsulosin
  •  go-up   go-down


13. Kaserman DL: Fifty years of organ transplants: the successes and the failures. Issues Law Med; 2007;23(1):45-69
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • During that time, substantial progress has been made in both surgical techniques and immunosuppressive drug therapy.
  • At the same time, however, many more thousands of patients have died while waiting in vain for a cadaveric donor organ to become available due to a severe and persistent shortage of such organs.
  • [MeSH-major] Jurisprudence. Transplants / history. Treatment Failure

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17703699.001).
  • [ISSN] 8756-8160
  • [Journal-full-title] Issues in law & medicine
  • [ISO-abbreviation] Issues Law Med
  • [Language] eng
  • [Publication-type] Historical Article; Journal Article
  • [Publication-country] United States
  •  go-up   go-down






Advertisement